Does EBV and CMV IgG positivity with negative IgM usually indicate past infection?

EBV and CMV are highly prevalent latent herpesviruses; their IgG antibodies commonly persist long term after infection. In an 83-year-old man, IgG positivity is therefore generally most consistent with remote exposure rather than a newly acquired acute infection when IgM is negative.

Clinical interpretation

• CMV: An IgG-positive/IgM-negative pattern most often indicates prior CMV infection and argues against acute primary CMV infection. IgG alone cannot date the infection or establish active CMV disease.
• EBV: The clearest remote-infection pattern is VCA IgG-positive, VCA IgM-negative, and EBNA IgG-positive. EBNA IgG generally develops after the acute phase and persists, supporting established immune memory.
• Thus, the core claim is well supported: negative IgM with positive IgG usually favors past exposure over acute primary infection.

Mechanistic and diagnostic considerations

• EBV and CMV establish lifelong latency; persistent virus-specific IgG reflects durable humoral immune memory, not necessarily ongoing clinically significant viral replication.
• EBV VCA IgG-positive/IgM-negative results without an EBNA measurement are less definitive: this can represent remote infection but may be indeterminate in early or atypical seroconversion.
• A negative IgM result does not absolutely exclude early infection, reactivation, or disease, particularly in immunocompromised patients, in whom IgM responses can be delayed or absent.
• When CMV reactivation or end-organ disease is clinically suspected in an immunocompromised person, quantitative CMV DNA PCR is more informative than IgM testing. Repeat serology, EBV immunoblotting, or IgG-avidity testing may occasionally clarify uncertain timing.

Bottom line

• Positive EBV/CMV IgG with negative IgM usually reflects previous infection and immune memory, not acute primary infection; EBV interpretation is strongest with concurrent EBNA IgG positivity, while symptoms and immune status determine whether molecular testing is needed.